In a scientific breakthrough that could reshape the future of drug development, researchers from IBM and Moderna have successfully used a quantum algorithm to simulate the longest mRNA sequence ever on a quantum computer, opening new horizons beyond the limits of current artificial intelligence.
Article contents:
- Introduction: a breakthrough in the world of molecular simulation
- The protein folding challenge: why is it so difficult?
- AI limits and the need for an alternative
- Experiment details: how was the quantum achievement accomplished?
- Breaking records
- Future potential: toward more effective vaccines
- Upcoming challenges in quantum computing
- Conclusion: quantum computing as a new force in biological sciences
Introduction: a breakthrough in the world of molecular simulation
Researchers at IBM and Moderna have successfully used a quantum simulation algorithm to predict the complex secondary structure of a 60-nucleotide messenger RNA (mRNA) sequence, the longest sequence ever simulated on a quantum computer. This achievement represents a major step toward overcoming the limitations of traditional computers and artificial intelligence models in understanding complex biological molecules, which could accelerate the development of more effective vaccines and treatments in the future.
The protein folding challenge: why is it so difficult?
Messenger ribonucleic acid (mRNA) is a molecule that carries genetic information from DNA to ribosomes, where it directs protein synthesis in cells. Although it consists of only a single strand of amino acids, mRNA has a secondary structure consisting of a series of folds that give the molecule its specific three-dimensional shape. This shape determines its function.
The problem is that the number of possible folding configurations increases exponentially with each additional nucleotide. This makes the challenge of predicting the shape that an mRNA molecule will take intractable at higher levels using traditional computers.
AI limits and the need for an alternative
Traditionally, these predictions have relied on classical binary computers and artificial intelligence models such as AlphaFold from Google DeepMind. Algorithms running on these classical architectures can process mRNA sequences containing “hundreds or thousands of nucleotides,” but only by excluding high-complexity features such as “pseudoknots.” These pseudoknots are twists and complex shapes in the molecule’s secondary structure capable of engaging in more complex internal interactions than normal folds. By excluding them, the accuracy of any protein folding prediction model is fundamentally limited. This is where quantum computing comes in.
Experiment details: how was the quantum achievement accomplished?
The IBM and Moderna experiment demonstrated how quantum computing can be used to enhance traditional methods. The researchers conducted multiple experiments using quantum simulation algorithms based on qubits—the quantum equivalent of a bit in a computer—to model molecules.
Using only 80 qubits (out of a possible 156) on the R2 Heron quantum processing unit, the team used a parameterized quantum algorithm (CVaR-based VQA)—a quantum optimization algorithm modeled on some techniques used to analyze complex interactions such as collision avoidance and financial risk assessment techniques—to predict the secondary structure of a 60-nucleotide mRNA sequence.
Breaking records
The previous best record for a quantum-based simulation model, according to the study, was a 42-nucleotide sequence. Moving to 60 nucleotides represents a significant leap in the ability to handle complexity. The researchers also scaled the experiment by applying modern error-correction techniques to deal with the noise generated by quantum functions, which is one of the biggest challenges in current quantum computing.
Future potential: toward more effective vaccines
Understanding and predicting the precise details of mRNA molecule protein folds is fundamental to developing stronger predictions, and thus more effective mRNA-based vaccines. By being able to accurately simulate these complex structures, including pseudoknots, scientists can design more stable and effective mRNA molecules to stimulate desired immune responses.
In the new study, the team demonstrated the initial effectiveness of the experimental model in running simulations of up to 156 qubits for mRNA sequences of up to 60 nucleotides. They also conducted preliminary research showing the potential to employ up to 354 qubits for the same algorithms in noise-free environments.
Upcoming challenges in quantum computing
Despite this exciting progress, the researchers noted that “these methods require the development of advanced techniques to embed these problem-specific circuits into current quantum hardware.” This indicates that better algorithms and processing architectures will be needed to advance the research. Quantum computing is still in its early stages, but this experiment shows that it is already beginning to tackle problems that exceed the capabilities of our most powerful supercomputers.
Conclusion: quantum computing as a new force in biological sciences
This collaboration between IBM and Moderna represents a pivotal moment as quantum computing moves from the realm of theory to practical application in one of the most important fields of biological science. By demonstrating the ability to simulate complex mRNA molecules in a way that surpasses current AI capabilities, this research opens the door to a new era of drug and vaccine design with unprecedented precision. Quantum computing may not be a complete replacement for artificial intelligence, but it stands out as an incredibly powerful tool that can solve certain types of problems that were previously considered unsolvable.
